Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, this FDA Warning Letter issued to Huaian Zongheng Bio-Tech Co., Ltd on January 9, 2020 concerns drug manufacturing or distribution operations. Without access to the full letter text or subject line details, the specific nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in this metadata summary.